Home
Adamas Pharmaceuticals

Adamas Pharmaceuticals Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainadamaspharma.com

Year Founded2002

Employees51 - 200

Annual Revenue$50M - $75M

Adamas Pharmaceuticals

Adamas Pharmaceuticals (including company regionals)

adamaspharma.com

See more website traffic and engagement information

Adamas Pharmaceuticals Revenue up to November 2025 is 50M - 75M

revenue generated by Adamas Pharmaceuticals top domains

Adamas Pharmaceuticals top domains revenue over 3 years

Revenue for Adamas Pharmaceuticals top domains

adamaspharma.com50M - 75M

See more with Sales Intelligence

Total visits to Adamas Pharmaceuticals's top domains

Understand Adamas Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Adamas Pharmaceuticals's top domains

Analyze Adamas Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Adamas Pharmaceuticals's top domains

See how Adamas Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Adamas Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

neuropace.comCompany NameNeuroPaceEmployees51 - 200HQUnited States, California, Mountain ViewAnnual revenue$50M - $75MTotal visits32.1KHealth > Health Conditions and Concerns

Top technologies used by Adamas Pharmaceuticals

These are the website technologies, by industry, used by Adamas Pharmaceuticals top domains

Advertising (6)

DoubleClick

Social (6)

Facebook Connect

Widget (6)

Twemoji

Conversion & Analytics (5)

Google Analytics

More Technologies

11

See all

News & Signals from Adamas Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsThe Company acquired Adamaspharma on Nov 1st '21.(1) The Company acquired Adamas Pharmaceuticals, Inc. in November 2021 (the "Adamas Acquisition").

NewsQuartel left Adamaspharma as Chief Medical Officer overseeing research and development on Jan 1st '20.Dr. Quartel joins Acer from Adamas Pharmaceuticals where he served as Chief Medical Officer overseeing research and development, as well as medical affairs and regulatory functions.

NewsAdamaspharma has issues with violated the federal securities laws.Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors of its investigation into whether the officers or directors of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN).